Scientists have discovered an antibody treatment that may help prevent both muscle loss and bone density loss in people using ...

The supply shortage and high costs of GLP-1 weight loss drugs have created an opportunity for compounded GLP-1 treatments to ...

Consequently, people using GLP-1 medications for weight loss may litigate ... For instance, at the start of 2024, the US list prices of Ozempic (Novo Nordisk) and Mounjaro (Eli Lilly) increased ...

Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Advocates say microdosing reduces costs and side effects while maintaining weight loss, then can help with weight maintenance ...

We know now that glucagon-like peptide 1 (GLP-1) drugs for obesity bring with them ... patients experienced a laundry list of positive health outcomes, including a reduced risk for: Substance ...

“The recent explosion in irresponsible and misleading advertising about compounded GLP-1 drugs ... when both drugs were added to the FDA's shortage list. When the FDA removed tirzepatide ...

The GLP-1 compound drug sold by Hims and Hers is not approved by the FDA and its Super Bowl ad fails to list any risks ...

Add surgical tweaks to fix so-called "Ozempic face" to the list of top trending cosmetic procedures, as tallied by the ...